Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs in Parkinson's disease
Maged M. Harraz, Ted M. Dawson, Valina L. Dawson
Journal of Chemical Neuroanatomy (2011) Vol. 42, Iss. 2, pp. 127-130
Open Access | Times Cited: 155

Showing 1-25 of 155 citing articles:

Polyphenols: Multipotent Therapeutic Agents in Neurodegenerative Diseases
Khushwant S. Bhullar, H.P. Vasantha Rupasinghe
Oxidative Medicine and Cellular Longevity (2013) Vol. 2013, pp. 1-18
Open Access | Times Cited: 378
MicroRNA-based therapeutics in central nervous system injuries
Ping Sun, Da Zhi Liu, Glen C. Jickling, et al.
Journal of Cerebral Blood Flow & Metabolism (2018) Vol. 38, Iss. 7, pp. 1125-1148
Open Access | Times Cited: 214
Parkinson's disease as a result of aging
Manuel Rodrı́guez, Clara Rodriguez‐Sabate, Ingrid Moráles, et al.
Aging Cell (2015) Vol. 14, Iss. 3, pp. 293-308
Open Access | Times Cited: 202
Role of Nuclear Factor Kappa B (NF-κB) Signalling in Neurodegenerative Diseases: An Mechanistic Approach
Shareen Singh, Thakur Gurjeet Singh
Current Neuropharmacology (2020) Vol. 18, Iss. 10, pp. 918-935
Open Access | Times Cited: 199
Genetics and Epigenetics of Parkinson's Disease
Fabio Coppedè
The Scientific World JOURNAL (2012) Vol. 2012, pp. 1-12
Open Access | Times Cited: 169
Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies
Kira Sheinerman, Samuil R. Umansky
Frontiers in Cellular Neuroscience (2013) Vol. 7
Open Access | Times Cited: 168
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy
Annamaria Vallelunga, Marco Ragusa, Stefania Di Mauro, et al.
Frontiers in Cellular Neuroscience (2014) Vol. 8
Open Access | Times Cited: 165
Long Non-Coding RNA and Alternative Splicing Modulations in Parkinson's Leukocytes Identified by RNA Sequencing
Lilach Soreq, Alessandro Guffanti, Nathan Salomonis, et al.
PLoS Computational Biology (2014) Vol. 10, Iss. 3, pp. e1003517-e1003517
Open Access | Times Cited: 162
Inhibition of miR‐34b and miR‐34c enhances α‐synuclein expression in Parkinson's disease
Savan Kabaria, Doo Chul Choi, Amrita Datta Chaudhuri, et al.
FEBS Letters (2014) Vol. 589, Iss. 3, pp. 319-325
Open Access | Times Cited: 156
Loss of MicroRNA-7 Regulation Leads to α-Synuclein Accumulation and Dopaminergic Neuronal Loss In Vivo
Kirsty J. McMillan, Tracey K. Murray, Nora Bengoa‐Vergniory, et al.
Molecular Therapy (2017) Vol. 25, Iss. 10, pp. 2404-2414
Open Access | Times Cited: 123
MicroRNA-7 Regulates the Function of Mitochondrial Permeability Transition Pore by Targeting VDAC1 Expression
Amrita Chaudhuri, Doo Chul Choi, Savan Kabaria, et al.
Journal of Biological Chemistry (2016) Vol. 291, Iss. 12, pp. 6483-6493
Open Access | Times Cited: 122
Downregulation of miR-124 in MPTP-treated mouse model of Parkinson’s disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins
Nandhini Kanagaraj, H. Beiping, S. Thameem Dheen, et al.
Neuroscience (2014) Vol. 272, pp. 167-179
Closed Access | Times Cited: 120
Mesenchymal Stem Cells Deliver Exogenous miRNAs to Neural Cells and Induce Their Differentiation and Glutamate Transporter Expression
Hae Kyung Lee, Susan Finniss, Simona Cazacu, et al.
Stem Cells and Development (2014) Vol. 23, Iss. 23, pp. 2851-2861
Closed Access | Times Cited: 113
Downregulated miR-29c correlates with increased BACE1 expression in sporadic Alzheimer's disease.
Xiaoguang Lei, Lei Ling, Z Zhang, et al.
International Journal of Clinical and Experimental Pathology (2015) Vol. 8, Iss. 2, pp. 1565-1574
Closed Access | Times Cited: 108
Nurr1‐Based Therapies for Parkinson's Disease
Jie Dong, Song Li, Jing‐Lin Mo, et al.
CNS Neuroscience & Therapeutics (2016) Vol. 22, Iss. 5, pp. 351-359
Open Access | Times Cited: 105
Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients
Elisa Caggiu, Kai Paulus, Giuseppe Mameli, et al.
eNeurologicalSci (2018) Vol. 13, pp. 1-4
Open Access | Times Cited: 105
A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson’s disease
Hui Dong, Cheng Wang, Sunbin Lu, et al.
Biomarkers (2015) Vol. 21, Iss. 2, pp. 129-137
Closed Access | Times Cited: 104
Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease
Seth A. Bennett, Royena Tanaz, Samantha N. Cobos, et al.
Translational research (2018) Vol. 204, pp. 19-30
Open Access | Times Cited: 104
Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
Alexandre Iarkov, George E. Barreto, J. Alex Grizzell, et al.
Frontiers in Aging Neuroscience (2020) Vol. 12
Open Access | Times Cited: 103
Plasma levels of miR-137 and miR-124 are associated with Parkinson’s disease but not with Parkinson’s disease with depression
Na Li, Xudong Pan, Jingli Zhang, et al.
Neurological Sciences (2017) Vol. 38, Iss. 5, pp. 761-767
Closed Access | Times Cited: 101
Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease
Jessica Schulz, Petros Takousis, Inken Wohlers, et al.
Annals of Neurology (2019) Vol. 85, Iss. 6, pp. 835-851
Open Access | Times Cited: 98
Emerging therapies for Parkinson's disease: From bench to bedside
Frank I. Tarazi, Zeyad T. Sahli, Martin Wolny, et al.
Pharmacology & Therapeutics (2014) Vol. 144, Iss. 2, pp. 123-133
Closed Access | Times Cited: 95
LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells
Yuan Chen, Yajun Lian, Yunqing Ma, et al.
NeuroToxicology (2017) Vol. 68, pp. 212-221
Closed Access | Times Cited: 92
Serum secreted miR-137-containing exosomes affects oxidative stress of neurons by regulating OXR1 in Parkinson’s disease
Yan Jiang, Jing Liu, Luzhu Chen, et al.
Brain Research (2019) Vol. 1722, pp. 146331-146331
Closed Access | Times Cited: 91
ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102327-102327
Closed Access | Times Cited: 14
Page 1 - Next Page

Scroll to top